TCL Archive NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization June 22, 1990
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983